Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04839705 · ClinicalTrials.gov registry record · NA
Post Approval Study - Evaluate the Long-Term Safety and Effectiveness of the WEB Device
A NA study of Wide Neck Bifurcation Intracranial Aneurysms, sponsored by Microvention-Terumo.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 20
- Study locations
NCT04839705: Recruiting NA study of Wide Neck Bifurcation Intracranial Aneurysms, sponsored by Microvention-Terumo.
NCT04839705 is a NA study of Wide Neck Bifurcation Intracranial Aneurysms that is actively recruiting participants, run by Microvention-Terumo. The registered enrollment target is 180 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). The trial reports 20 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04839705, a NA study of Wide Neck Bifurcation Intracranial Aneurysms, is actively recruiting participants, sponsored by Microvention-Terumo.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 20
- Study locations
Study Summary
A prospective, multicenter, single arm, interventional study. The target patient population for this study are adult subjects with WNBAs of the anterior and posterior intracranial circulation. The primary effectiveness outcome of the study is adequate intracranial aneurysm occlusion on the 1 year angiogram as adjudicated by a core laboratory.
Primary Outcome
Proportion of subjects with adequate aneurysm occlusion at one year after treatment.
Conditions Studied
Interventions
- DEVICE WEB
Study Locations (20)
New York
- Albany Medical Center - Albany
- University of Buffalo - Buffalo
- Northshore University Hospital/Northwell Health - Manhasset
- SUNY Stony Brook - Stony Brook
- Montefiore Medical Center - The Bronx
Kentucky
- Baptist Health Systems - Lexington
- University of Kentucky, Department of Neurosurgery - Lexington
- Norton Healthcare - Louisville
Florida
- Memorial Health Systems - Hollywood
- Orlando Health Neuroscience Institute - Orlando
Maryland
- University of Maryland, Baltimore - Baltimore
- Johns Hopkins University - Baltimore
Massachusetts
- Massachusetts General Brigham Incorporated - Boston
- UMass Memorial Health - Worcester
Hawaii
- The Queen's Medical Center Neuroscience Institute - Honolulu
Iowa
- University of Iowa Hospitals and Clinics - Iowa City
Kansas
- University of Kansas Health System - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2022-08-24 |
| Est. Completion | 2029-12 |
| Phase | NA |
What NCT04839705 shows while recruiting
NCT04839705 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Wide Neck Bifurcation Intracranial Aneurysms appearing as the primary indexed condition, and to 1 intervention - of which WEB is the first listed.
NCT04839705 names 20 study sites across 11 states, led by New York, Kentucky, Florida.
Frequently Asked Questions
What is clinical trial NCT04839705 about?
NCT04839705 is a clinical study titled "Post Approval Study - Evaluate the Long-Term Safety and Effectiveness of the WEB Device". A prospective, multicenter, single arm, interventional study. The target patient population for this study are adult subjects with WNBAs of the anterior and posterior intracranial circulation. The primary effectiveness outcome of the study is adequate intracranial aneurysm occlusion on the 1 year an...
What is the current status of trial NCT04839705?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2022-08-24. Estimated completion is 2029-12.
What conditions does trial NCT04839705 study?
This clinical trial studies the following conditions: Wide Neck Bifurcation Intracranial Aneurysms.
What interventions are being tested in trial NCT04839705?
The interventions under investigation include: WEB (DEVICE).
Who is sponsoring clinical trial NCT04839705?
This trial is sponsored by Microvention-Terumo, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04839705 being conducted?
This trial has 20 study locations across Florida, Hawaii, Iowa, Kansas, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04839705's enrollment target sits among peer trials
180 586th of 2000 higher than 1,397 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI